Capital Fund Management (CFM)’s Meridian Bioscience Inc VIVO Stock Holding History

Capital Fund Management (CFM)’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,900	Closed	-$113K	–	2090
2019 Q3	$113K	Buy	11,900 +300	+3%	+$3.16K	﹤0.01%	1607
2019 Q2	$138K	Buy	+11,600	New	+$140K	﹤0.01%	1546
2016 Q3	–	Sell	-41,000	Closed	-$800K	–	1850
2016 Q2	$800K	Buy	+41,000	New	+$804K	0.01%	1024
2015 Q1	–	Sell	-11,500	Closed	-$189K	–	1809
2014 Q4	$189K	Buy	+11,500	New	+$197K	﹤0.01%	1505
2014 Q3	–	Sell	-11,000	Closed	-$227K	–	1894
2014 Q2	$227K	Sell	11,000 -2,412	-18%	-$49.6K	﹤0.01%	1535
2014 Q1	$292K	Buy	+13,412	New	+$307K	﹤0.01%	1489
2013 Q3	–	Sell	-18,835	Closed	-$405K	–	1971
2013 Q2	$405K	Buy	+18,835	New	+$406K	0.01%	1054

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Capital Fund Management (CFM)'s VIVO Position: Q4 2019 in Review

Capital Fund Management (CFM) sold out of Meridian Bioscience Inc (VIVO) in Q4 2019, closing a stake of 11,900 shares — an estimated $113K sold.

Capital Fund Management (CFM) first reported a position in VIVO in Q2 2013 and held it in 7 quarters. The position peaked at $800K in Q2 2016. 170 funds tracked by Wall St. Rank hold VIVO as of Q4 2019.

Capital Fund Management (CFM) reported no remaining Meridian Bioscience Inc position as of Q4 2019 after selling out during the quarter.
Capital Fund Management (CFM) sold 11,900 Meridian Bioscience Inc shares in Q4 2019, an estimated $113K.
Capital Fund Management (CFM) first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 7 quarters.
Capital Fund Management (CFM)'s Meridian Bioscience Inc position peaked at $800K in Q2 2016.
170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2019.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2019, filed 13 Feb 2020.